PCSK9 and hyperlipidemia: We utilized the terms for Medical Subject Heading (MeSH) strategy using the keywords arranged into the following concepts: Concept A, “Chronic Kidney Disease"; Concept B, “Hyperlipidemia” OR “DYSLIPIDEMIA”; Concept C; “Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9 Inhibitors )” OR “Alirocumab” OR “Evolocumab”; Concept D: "Hydroxymethylglutaryl-Coa Reductase Inhibitors” OR “Statins” OR“ Atorvastatin “OR “ Simvastatin.” We searched these concepts in two combinations.